Links to all abstracts Hammersmith 2011.

Click here for details of Endocrine Symposium http://metmed.info

Oral Presentations

OC1 Escape from medical therapy in a severely ill patient with Cushing’s disease

OC2 Successful control of Cushing’s disease in pregnancy with unilateral adrenalectomy following failed transsphenoidal hypophysectomy

OC3 A Single Centre Assessment of Pituitary Radiotherapy

OC4 Management of an aggressive parathyroid tumour co-existing with vitamin D deficiency

OC5 To D or not to D – should clinicians be encouraged to replace vitamin D when managing patients with primary hyperparathyroidism

OC6 Right Retroperitoneoscopic Adrenalectomy for Phaeochromocytoma Following Partial Hepatectomy for MEN 2B Associated Medullary Thyroid Cancer.

OC7 An unusual presentation of adrenocortical carcinoma.

OC8 Investigation of gastric carcinoid using the secretin test

OC9 Hypercalcaemia due to PTH-related peptide (PTHrP) secreting pancreatic neuroendocrine tumour, responsive to sunitinib treatment

Poster Presentations

R001 Cerebral Salt Wasting Syndrome after Subarachnoid Haemorrhage: a case report

R002 Audit of Pituitary Dysfunction after Traumatic Brain Injury: Caution in Interpretation of Glucagon Stimulation Test in Diagnosis of GH and ACTH Deficiency.

R003 An unusual presentation of adrenocortical carcinoma.

R004 Outcomes of Transsphenoidal Surgery for Growth Hormone-secreting microadenomas at our centre: A comparison with the literature.

R005 Lutetium-177 DOTATE for paraganglioma refractory to conventional chemotherapy. A case report.

R006 A rare case of periodic hypokalaemic paralysis secondary to Graves’ thyrotoxicosis

R007 Right Retroperitoneoscopic Adrenalectomy for Phaeochromocytoma Following Partial Hepatectomy for MEN 2B Associated Medullary Thyroid Cancer

R008 Campath Induced Hyperthyroidism

R009 Dysphagia caused by Graves thyrotoxicosis

R010 Graves’ Disease associated with Langerhans Cell Histiocytosis

R011 Hypercalcaemia due to primary hyperparathyroidism: variability of symptomatology illustrated by two case presentations.

R012 Improving Glycaemic Control in Prader-Willi Syndrome with the GLP-1 analogue Liraglutide

R013 Primary hyperaldosteronism in pregnancy

R014 Phaeochromocytoma in pregnancy

R015 Successful control of Cushing’s disease in pregnancy with unilateral adrenalectomy following failed transsphenoidal hypophysectomy

R016 Management of an aggressive parathyroid tumour co-existing with vitamin D deficiency

R017 A case of Langerhans cell histiocytosis of the thyroid gland.

R018 Hypercalcaemia due to PTH-related peptide (PTHrP) secreting pancreatic neuroendocrine tumour, responsive to sunitinib treatment

R019 Subclinical Cushing syndrome and adrenal incidentaloma

R020 X-linked adrenoleukodystrophy

R021 To D or not to D – should clinicians be encouraged to replace vitamin D when managing patients with primary hyperparathyroidism

R022 ANCA positive renal vasculitis in Carbimazole treated patient

R023 Investigation of gastric carcinoid using the secretin test

R024 Asymptomatic severe hypercalcaemia following excessive chronic intake

R025 Resistant prolonged hypocalcaemia following surgery treated with teriparatide

R026 Recurrent atypical adrenocorticotrophic hormone (ACTH) secreting carcinoid causing Cushing`s syndrome.

R027 Expression of Somatostatin Receptors in Phaeochromocytoma and Paragangliomas

R028 Pamidronate (bisphosphonate)- induced Pyrexia - is not uncommon.

R029 A case of insulin dependent diabetes following insulinoma treatment

R030 Hyponatraemia: Be(er) Aware

R031 Thyrotoxicosis associated with Munchhausen’s disease

R032 The Forgetful Tailor: Case Report of an Ectopic Mediastinal Parathyroid Adenoma

R033 Two Mechanisms for Neutropenia in a Thyrotoxic Patient

R034 A difficult case of thyrotoxicosis - or was it

R035 Quantifying the effects of renal impairment on plasma levels of neuroendocrine neoplasia biomarkers

R036 Parathyroidectomy in Chronic Kidney Disease 2006-11: Success comes at a price

R037 A Single Centre Assessment of Pituitary Radiotherapy

R038 Opioid-induced ACTH deficiency or anterior panyhypopituitarism

R039 Severe Thyrotoxicosis: A Rare Cause of Hypercalcemia

R040 Lithium is a useful adjuvant in patients receiving radioactive iodine for hyperthyroidism

R041 Escape from medical therapy in a severely ill patient with Cushing’s disease